altretamine has been researched along with Plasma Cell Tumor in 4 studies
Altretamine: A hexamethyl-2,4,6-triamine derivative of 1,3,5-triazine.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Pharmacokinetic studies in mouse, rat and man did not show the major species differences characteristic of PMM." | 1.27 | Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation. ( Abel, G; Goddard, PM; Harrap, KR; Judson, IR; Newell, DR; Rutty, CJ, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Morimoto, M | 1 |
| Green, D | 1 |
| Rahman, A | 1 |
| Goldin, A | 1 |
| Schein, PS | 1 |
| Cumber, AJ | 1 |
| Ross, WC | 1 |
| Paolini, A | 1 |
| D'Incalci, M | 1 |
| Rutty, CJ | 1 |
| Judson, IR | 1 |
| Abel, G | 1 |
| Goddard, PM | 1 |
| Newell, DR | 1 |
| Harrap, KR | 1 |
4 other studies available for altretamine and Plasma Cell Tumor
| Article | Year |
|---|---|
Comparative pharmacology of pentamethylmelamine and hexamethylmelamine in mice.
Topics: Alkylating Agents; Altretamine; Animals; DNA Replication; DNA, Neoplasm; Leukocyte Count; Male; Mice | 1980 |
Analogues of hexamethylmelamine. The anti-neoplastic activity of derivatives with enhanced water solubility.
Topics: Altretamine; Animals; Humans; Lung Neoplasms; Mice; Neoplasm Transplantation; Neoplasms, Experimenta | 1977 |
Effect of phenobarbital pretreatment on the metabolism and antitumor activity of hexamethylmelamine.
Topics: Altretamine; Animals; Cell Line; Chromatography, Gas; Drug Interactions; Female; Kinetics; Male; Mic | 1986 |
Preclinical toxicology, pharmacokinetics and formulation of N2,N4,N6-trihydroxymethyl-N2,N4,N6-trimethylmelamine (trimelamol), a water-soluble cytotoxic s-triazine which does not require metabolic activation.
Topics: Altretamine; Animals; Antineoplastic Agents; Carcinoma 256, Walker; Chromatography, High Pressure Li | 1986 |